Provista Life Sciences LLC Consolidates Management Of GW Medical Technologies, LLC, RCP Diagnostics, Biomarker Technologies LLC

Published: Dec 08, 2006

PHOENIX--(BUSINESS WIRE)--Provista Life Sciences LLC (PLS) announced today it will consolidate and oversee the management and operations of three biotech diagnostic development companies: GW Medical Technologies LLC, Biomarker Technologies LLC and RCP Diagnostics LLC. Under this arrangement, the companies will share PLS’ management team, grant writing, fund-raising and research & development resources while continuing to advance their independent areas of applied clinical study.

>>> Discuss This Story

Back to news